Sign in
8-K

Current Report

Cardiff Oncology, Inc. Filed Acc 0001321543-06-000104

Material agreement · Restatement · Executive or director change

  • Item 1.01 Entry into a material definitive agreement
  • Item 4.02 Non-reliance on previously issued financial statements
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading maindoc.htm…